News Column

Pathfinder Cell Therapy, Inc. Files SEC Form 5, Annual Statement of Changes in Beneficial Ownership of Securities (Apr. 29, 2014)

May 14, 2014

By a News Reporter-Staff News Editor at Biotech Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Pathfinder Cell Therapy, Inc. (Form 5) was posted on April 29, 2014.

The SIC code for this company is 3842, Orthopedic, Prosthetic and Surgical Appliances and Supplies.

There was one document filed with this form. The SEC file number is 0001531041-14-000002.

The contact information for this company is 12 BOW STREET, CAMBRIDGE MA 02138, 6172450289.

Our editors provided additional information about Form 5: Every director, officer or owner of more than ten percent of a class of equity securities registered under Section 12 of the '34 Act must file with the Commission a statement of ownership regarding such security. The initial filing is on Form 3 and changes are reported on Form 4. The Annual Statement of beneficial ownership of securities is on Form 5. The forms contain information on the reporting person's relationship to the company and on purchases and sales of such equity securities.

A U.S. Securities and Exchange Commission filing is a formal document or financial statement submitted to the SEC by publicly-traded companies.

For additional information on this SEC filing see:

Keywords for this news article include: Biotechnology, Orthopedic, SEC Filing, Biological Therapy, Pathfinder Cell Therapy Inc., Prosthetic and Surgical Appliances and Supplies.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC

For more stories covering the world of technology, please see HispanicBusiness' Tech Channel

Source: Biotech Week